DOSSIER · 13F-HR · Q2 2026

Bellevue Group AG

$4.8B in tracked AUM across 164 positions as of Q2 2026.

BG
CIK 0001674546 · last filed Jun 30, 2026
Total AUM
$4.8B
as of Q2 2026
Holdings
164
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Portfolio Overview

Bellevue Group AG's 13F filing for the period ending September 30, 2025, reveals a portfolio undergoing significant consolidation and strategic reallocation. The total portfolio value decreased by 32.6%, dropping from $4.54 billion to $3.06 billion. This substantial reduction in assets under management (AUM) is driven not only by potential market depreciation but also by a high level of trading activity, with 42 positions either added or liquidated (21 new, 21 sold). The ...

Key Holdings

The portfolio is characterized by a high-conviction approach to biotechnology and pharmaceuticals, with the top five positions all belonging to the healthcare sector and commanding nearly 43% of the total assets.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
AMGN
AMGEN INC
$308M852K6.5%
02
VRTX
VERTEX PHARMACEUTICALS INC
$287M579K6.0%
03
ARGX
ARGENX SE
$279M301K5.9%
04
GILD
GILEAD SCIENCES INC
$273M2.2M5.7%
05
RVMD
REVOLUTION MEDICINES INC
$196M1.0M4.1%
06
ORKA
ORUKA THERAPEUTICS INC
$158M1.7M3.3%
07
INSM
INSMED INC
$149M1.4M3.1%
08
SRRK
SCHOLAR ROCK HLDG CORP
$135M2.4M2.8%
09
NUVL
NUVALENT INC
$130M1.1M2.7%
10
VRDN
VIRIDIAN THERAPEUTICS INC
$124M6.7M2.6%

Filing history

2026Q2Jun 30
$4.8B 9.9%
164 positionsView →
2025Q4Dec 31
$5.3B 72.6%
213 positionsView →
2025Q3Sep 30
$3.1B 32.6%
115 positionsView →
2025Q2Jun 30
$4.5B 1.7%
175 positionsLocked
2025Q1Mar 31
$4.5B 14.1%
177 positionsLocked
2024Q4Dec 31
$5.2B 15.8%
193 positionsLocked
2024Q3Sep 30
$6.2B 0.3%
196 positionsLocked
2024Q2Jun 30
$6.2B 6.1%
204 positionsLocked
2024Q1Mar 31
$6.6B 0.3%
208 positionsLocked
2023Q4Dec 31
$6.5B 5.3%
202 positionsLocked
2023Q3Sep 30
$6.2B 11.5%
196 positionsLocked
2023Q2Jun 30
$7.0B 1.7%
198 positionsLocked
Showing 12 of 38